Targeted Genetics Inherits Biogen & Genzyme Alliances In Genovo Acquisition
Executive Summary
Targeted Genetics will inherit partnerships with Biogen and Genzyme when it completes the acquisition of Genovo, according to an Aug. 9 merger agreement.
You may also be interested in...
FDA Planning More Inspections Of Gene Therapy Trials During IND Phase
FDA plans to step up inspections of gene therapy trials while they are in the IND phase, FDA Office of Therapeutics Research & Review Director Jay Siegel, MD, told the Senate Health/Public Health Subcommittee during a Feb. 2 hearing on gene therapy.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials